Drugs / 1 alpha D2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00560300 | Nov 2000 → Nov 2006 | renal osteodystrophy | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 1 alpha D2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00560300 ↗ |